Literature DB >> 23114772

Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar.

Vanaporn Wuthiekanun1, Premjit Amornchai, Daniel H Paris, Sayan Langla, Janjira Thaipadunpanit, Wirongrong Chierakul, Lee D Smythe, Nicholas J White, Nicholas P J Day, Direk Limmathurotsakul, Sharon J Peacock.   

Abstract

Pathogenic Leptospira spp., the causative agents of leptospirosis, are slow-growing Gram-negative spirochetes. Isolation of Leptospira from clinical samples and testing of antimicrobial susceptibility are difficult and time-consuming. Here, we describe the development of a new solid medium that facilitates more-rapid growth of Leptospira spp. and the use of this medium to evaluate the Etest's performance in determining antimicrobial MICs to drugs in common use for leptospirosis. The medium was developed by evaluating the effects of numerous factors on the growth rate of Leptospira interrogans strain NR-20157. These included the type of base agar, the concentration of rabbit serum (RS), and the concentration and duration of CO(2) incubation during the initial period of culture. The highest growth rate of NR-20157 was achieved using a Noble agar base supplemented with 10% RS (named LVW agar), with an initial incubation at 30°C in 5% CO(2) for 2 days prior to continuous culture in air at 30°C. These conditions were used to develop the Etest for three species, L. interrogans (NR-20161), L. kirschnerii (NR-20327), and L. borgpetersenii (NR-20151). The MICs were read on day 7 for all samples. The Etest was then performed on 109 isolates of pathogenic Leptospira spp. The MIC(90) values for penicillin G, doxycycline, cefotaxime, ceftriaxone, and chloramphenicol were 0.64 units/ml and 0.19, 0.047, 0.5, and 2 μg/ml, respectively. The use of LVW agar, which enables rapid growth, isolation of single colonies, and simple antimicrobial susceptibility testing for Leptospira spp., provides an opportunity for new areas of fundamental and applied research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114772      PMCID: PMC3535913          DOI: 10.1128/AAC.01812-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Isolation of Leptospira of the serotype hardjo from bovine kidneys.

Authors:  H S Orr; T W Little
Journal:  Res Vet Sci       Date:  1979-11       Impact factor: 2.534

3.  Broth microdilution susceptibility testing for Leptospira spp.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 4.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

5.  Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis.

Authors:  G Watt; L P Padre; M L Tuazon; C Calubaquib; E Santiago; C P Ranoa; L W Laughlin
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

6.  LEPTOSPIRAL COLONIAL MORPHOLOGY.

Authors:  O H STALHEIM; J B WILSON
Journal:  J Bacteriol       Date:  1963-09       Impact factor: 3.490

7.  An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis.

Authors:  Yupin Suputtamongkol; Kanigar Niwattayakul; Chuanpit Suttinont; Kitti Losuwanaluk; Roongroeng Limpaiboon; Wirongrong Chierakul; Vanaporn Wuthiekanun; Surapee Triengrim; Mongkol Chenchittikul; Nicholas J White
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079

8.  Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis.

Authors:  Direk Limmathurotsakul; Elizabeth L Turner; Vanaporn Wuthiekanun; Janjira Thaipadungpanit; Yupin Suputtamongkol; Wirongrong Chierakul; Lee D Smythe; Nicholas P J Day; Ben Cooper; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

9.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16

10.  A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand.

Authors:  Janjira Thaipadungpanit; Vanaporn Wuthiekanun; Wirongrong Chierakul; Lee D Smythe; Wimol Petkanchanapong; Roongrueng Limpaiboon; Apichat Apiwatanaporn; Andrew T Slack; Yupin Suputtamongkol; Nicholas J White; Edward J Feil; Nicholas P J Day; Sharon J Peacock
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31
View more
  13 in total

Review 1.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Antibiotic Efficacy in Eliminating Leptospiruria in California Sea Lions (Zalophus californianus) Stranding with Leptospirosis.

Authors:  K C Prager; David P Alt; Michael G Buhnerkempe; Denise J Greig; Renee L Galloway; Qingzhong Wu; Frances M D Gulland; James O Lloyd-Smith
Journal:  Aquat Mamm       Date:  2015-05-26       Impact factor: 1.382

3.  Towards routine employment of computational tools for antimicrobial resistance determination via high-throughput sequencing.

Authors:  Simone Marini; Rodrigo A Mora; Christina Boucher; Noelle Robertson Noyes; Mattia Prosperi
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

4.  Serological and molecular epidemiology of leptospirosis and the role of dogs as sentinel for human infection in Nigeria.

Authors:  Nicholas N Pilau; Aristea A Lubar; Aminu I Daneji; Usman M Mera; Abdullahi A Magaji; Elmina A Abiayi; Kira L Chaiboonma; Emmanuel I Busayo; Joseph M Vinetz; Michael A Matthias
Journal:  Heliyon       Date:  2022-05-21

5.  Maintenance of leptospira species in leptospira Vanaporn Wuthiekanun agar.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Sayan Langla; Malinee Oyuchua; Nicholas P J Day; Direk Limmathurotsakul
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

6.  Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Sayan Langla; Nicholas J White; Nicholas P J Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

7.  Leptospira species in floodwater during the 2011 floods in the Bangkok Metropolitan Region, Thailand.

Authors:  Janjira Thaipadungpanit; Vanaporn Wuthiekanun; Narisara Chantratita; Surapon Yimsamran; Premjit Amornchai; Siriphan Boonsilp; Wanchai Maneeboonyang; Prapin Tharnpoophasiam; Natnaree Saiprom; Yuvadee Mahakunkijcharoen; Nicholas P J Day; Pratap Singhasivanon; Sharon J Peacock; Direk Limmathurotsakul
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

8.  Quality controls for antimicrobial disk diffusion testing on Leptospira Vanaporn Wuthiekanun agar.

Authors:  Vanaporn Wuthiekanun; Nicholas J White; Premjit Amornchai; Nicholas P J Day; Direk Limmathurotsakul
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-11-01       Impact factor: 2.184

Review 9.  Leptospirosis: risk factors and management challenges in developing countries.

Authors:  Cyrille Goarant
Journal:  Res Rep Trop Med       Date:  2016-09-28

10.  Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis.

Authors:  Marga G A Goris; Mariska M G Leeflang; Martin Loden; Jiri F P Wagenaar; Paul R Klatser; Rudy A Hartskeerl; Kimberly R Boer
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.